Liver argininosuccinate synthase binds to bacterial lipopolysaccharides and lipid A and inactivates their biological activities

Journal of Endotoxin Research

Volumn 12, Issue 1, 2006, Pages 21-38

  Satoh, Motonobu ^a   Iwahori, Tsuguya ^a   Sugawara, Naoki ^a   Yamazaki, Masatoshi ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Argininosuccinate synthase; Clearance; Endotoxin; Lipid A; Liver

Indexed keywords

ARGININOSUCCINATE SYNTHASE; BACTERIUM LIPOPOLYSACCHARIDE; LIPID A; LIVER PROTEIN;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTICLE; DETOXIFICATION; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME PURIFICATION; FEMALE; GEL ELECTROPHORESIS; IMMUNOPRECIPITATION; INHIBITION KINETICS; INNATE IMMUNITY; LIVER FUNCTION; MALE; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; ANIMALS; ARGININOSUCCINATE SYNTHASE; BACTERIA; CATS; CELL LINE; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ESCHERICHIA COLI; FEMALE; FIBROBLASTS; IMMUNOPRECIPITATION; LIPID A; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C3H; PROTEINS; SALMONELLA;

ANIMALIA; BACTERIA (MICROORGANISMS); LIMULUS;

EID: 31644444564     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1179/096805106X89062     Document Type: Article

References (57)

1. Nowotny A. Review of molecular requirements of endotoxic reactions. Rev Infect Dis 1987; 9: 503-511.
2. Morrison DC, Ryan JL. Bacterial endotoxin and host immune response. Adv Immunol 1983; 28: 293-452.
3. Macintire DK, Bellhorn TL. Bacterial translocation: clinical implications and prevention. Vet Clin North Am Small Anim Pract 2002; 32: 1165-1178.
4. Lichtman SM. Bacterial translocation in humans. J Pediatr Gastruenteral Nutr 2001; 33: 1-10.
5. Knapp S, Branger J, van der Poll T. Advances in research of the inflammatory response: the importance of Toll-like receptors. Wien Med Wochenschr 2002; 152: 552-554.
6. Muroi M, Ohnishi T, Tanamoto K. Regions of the mouse CD14 molecule required for Toll-like receptor 2- and 4-mediated activation of NF-κB. J Biol Chem 2002; 277: 42372-42379.
7. Gutsmann T, Muller M, Carroll SF et al. Dual role of lipopolysaccharide (LPS)-binding protein in neutralization of LPS and enhancement of LPS-induced activation of mononuclear cells. Infect Immun 2001; 69: 6942-6950.
8. Thomas CJ, Kapoor M, Sharma S et al. Evidence of a trimolecular complex involving LPS, LPS binding protein and soluble CD14 as an effector of LPS response. FEBS Lett 2002; 531: 184-188.
9. Little RG, Kelner DN, Lim E, Burke DJ, Conlon PJ. Functional domains of recombinant bactericidal/permeability increasing protein (rBP123). J Biol Chem 1994; 269: 1865-1872.
10. Larrick JW, Hirata M, Zheng H et al. A novel granulocyte-derived peptide with lipopolysaccharide-neutralizing activity. J Immunol 1994; 152: 231-240.
11. Elass-Rochard E, Roseanu A, Legrand D et al. Lactoferrin-lipopolysaccharide interaction involvement of the 28-34 loop region of human lactoferrin in the high affinity binding to Escherichia coli O55:B5 lipopolysaccharide. Biochem J 1995; 312:839-845.
12. de Haas CJ, van der Tol ME, Van Kessel KP, Verhoef J, Van Strijp JA. A synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. J Immunol 1998; 161: 3607-3615.
13. Yang H, Wang H, Bernik TR et al. Globin attenuates the innate immune response to endotoxin. Shock 2002; 17: 485-490.
14. Lehrer RI, Ganz T. Endogenous vertebrate antibiotics. Defensins, protegrins, and other cysteine-rich antimicrobial peptides. Ann NY Acad Sci 1996; 797: 228-239.
15. Zanetti M, Gennaro R, Romeo D. The cathelicidin family of antimicrobial peptide precursors: a component of the oxygen-independent defense mechanisms of neutrophils. Ann NY Acad Sci 1997; 832: 147-162.
16. Sano H, Chiba H, Iwaki D, Sohma. H, Voelker DR, Kuroki Y. Surfactant proteins A and D bind CD14 by different mechanisms. J Biol Chem 2000; 275: 22442-22451.
17. Kitchens RL, Munford RS. CD-14-dependent internalization of bacterial lipopolysaccharide (LPS) is strongly influenced by LPS aggregation but not by cellular responses to LPS. J Immunol 1998; 160: 1920-1928.
18. Gegner JA, Ulevitch RJ, Tobias PS. Lipopolysaccharide (LPS) signal transduction and clearance. Dual roles for LPS binding protein and membrane CD14. J Biol Chem 1995; 270; 5320-5325.
19. Hewett JA, Roth RA. Hepatic and extralrepatic pathobiology of bacterial lipopolysaccharides. Pharmacol Rev 1993; 45: 382-411.
20. Harris HW, Grunfeld C, Feingold KR et al. Chylonricrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993; 91: 1028-1034.
21. Harris HW, Brady SE, Rapp JH. Hepatic endosomal trafficking of lipoprotein-bound endotoxin in rats. Surg Res 2002; 106: 188-195.
22. Reynolds JV, Murchan P, Leonard N, Clarke P, Keane FB, Tanner WA. Gut barrier failure in experimental obstructive jaundice. J Surg Res 1996; 62: 11-16.
23. Kakkos SK, Kirkilesis J, Scopa CD, Arvaniti A, Alexandrides T, Vagianos CE. Nonabsorbable antibiotics reduce bacterial and endotoxin translocation in hepatectomised rats. HPB Surg 1997; 10: 283-289.
24. Hori Y, Takeyama Y, Ueda T, Nishikawa J, Yamamoto M, Saitoh Y. Impaired transport of lipopolysacchadde across the hepatocytes in rats with cerulein-induced experimental pancreatitis. Pancreas 1998; 16: 148-153.
25. Satoh M, Matsumura T, Nakamoto M, Yamazaki M. Inhibition of TNF-triggering activity of lipopolysaccharide by a proteinaceous factor from normal mouse liver extract. J Immunol 1995; 155: 877-885.
26. Saheki T, Sase M, Nakano K, Azuma F, Katsunuma T. Some properties of argininosuccinate synthetase purified from human liver and a comparison with the rat liver enzyme. J Biochem 1983; 93; 1531-1537.
27. Xie L, Gross SS. Argininosuccinate synthetase overexpression in vascular smooth muscle cells potentiates immunostimulant-induced NO production. J Biol Chem 1997; 272: 16624-16630.
28. Laemmli UK. Cleavage of structural proteins during the assembly of the bead of bacteriophage T4. Nature 1970; 227: 680-685.
29. Schëgger HJ, von Jagow G. Tricine-sodium dodecyl sulfate-polyacrylamide gel electrophoresis for the separation of protein in the range from 1 to 100 kDa. Anal Biochem 1987; 166: 368-379.
30. Surh LC, Beaudet AL, O'Brien WE. Molecular characterization of the murine argininosuccinate synthetase locus. Gene 1991; 99: 181-189.
31. Fengsrud M, Raiborg C, Berg TO et al. Autophagosome-associated variant isoforms of cytosolic enzymes. Biochem J 2000;352:773-781.
32. Saheki T, Kusumi T, Takada S, Katsunuma T. Crystallization and some properties of argininosuccinate synthase from rat liver. FEBS Lett 1975; 58: 314-317.
33. Rochovansky O, Kodowaki H, Ratner S. Biosynthesis of urea. Molecular and regulatory properties of crystalline argininosuccinate synthetase. J Biol Chem 1977; 252: 5287-5294.
34. Imamura Y, Kobayashi K, Yamashita T et al. Clinical application of enzyme inummoassay in the analysis of citrullinemia. Clin Chim Acia 1987; 164: 201-208.
35. Homma JY, Matsuura M, Kanegasaki S et al. Structural requirement of lipid A responsible for the functions: a study with chemically synthesized lipid A and its analogues. J Biochem 1985;98:395-406.
36. Zhang X, Morrison DC. Lipopolysaccharide structure-function relationship in activation versus reprogramming of mouse peiritonealmacrophages. J Leukoc Biol 1993; 54: 444-450.
37. Kusunoki T, Hailman E, Juan TS, Lichenstein HS, Wright SD. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J Exp Med 1995; 182: 1673-1682.
38. Takada S, Kusumi T, Saheki T, Tsuda M, Katsunuma T. Studies of rat liver argininosuccinate synthetase. The presence of three forms, and their physicochemical, catalytic, and immunochemical properties. J Biochem 1979; 86: 1353-1359.
39. Iovine N, Eastvold J, Elsbach P, Weiss JP, Gioannini TL. The carboxyl-terminal domain of closely related endotoxin-binding proteins determines the target of protein-lipopolysaccharide complexes. J Biol Chem 2002; 277: 7970-7978.
40. Lei M-G, Stimpson SA, Morrison DC. Specific endotoxic lipopolysaccharide-binding receptors on murine splenocytes. III. Binding specificity and characterization. J Immunol 1991; 147: 1925-1932.
41. Mueller M, Lindner B, Kusumoto S et al. Aggregates are the biologically active units of endotoxin. J Biol Chem 2004; 279: 26307-26313.
42. Caccavo D, Afeltra A, Pece S et al. Lactoferrin-lipid A-lipopoly-saccharide interaction: inhibition by anti-human lactoferrin monoclonal antibody AGM 10.14. Infect Immun 1999; 67: 4668-4672.
43. Jiao B, Freudenberg M, Galanos C. Characterization of the lipid A component of genuine smooth-form lipopolysaccharide. Eur J Biochem 1989; 180: 515-518.
44. Taylor AH, Heavner G, Nedelman M et al. Lipopolysaccharide (LPS) neutralizing peptides reveal a lipid A binding site of LPS binding protein. J Biol Chem 1995; 270: 17934-17938.
45. Hoess A, Schneider-Mergener J, Liddington RC, Identification of the LPS-binding domain of an endotoxin neutralising protein, Limulus anti-LPS factor. Prog Clin Biol Res 1995; 392: 327-337.
46. Augusto LA, Li J, Synguelakis M, Johansson J, Chaby R. Structural basis for interactions between lung surfactant protein C and bacterial lipopolysaccharide. J Biol Chem 2002; 277: 23484-23492.
47. Elass E, Masson M, Mazurier J, Legrand D. Lactoferrin inhibits the lipopolysaccharide-induced expression and proteoglycan-binding ability of interleukin-8 in human endothelial cells. Infect Immun 2002; 70: 1860-1866.
48. Husson A, Brasse-Lagnel C, Fairand A, Renouf S, Lavoinne A. Argininosuccinate synthetase from the urea cycle to the citrulline-NO cycle. Eur J Biochem 2003; 270: 1887-1899.
49. Wu G, Morris Jr SM. Arginine metabolism: nitric oxide and beyond. Biochem J 1998; 336: 1-17.
50. Wu GY, Brosnan JT. Macrophages can convert citrulline into arginine. Biochem J 1992; 281: 45-48.
51. Bogdan C. Nitric oxide and the immune response. Nat Immunol 2001; 2: 907-916.
52. McCormick SM, Eskin SG, McIntire LV et al. DNA microarray reveals changes in gene expression of shear stressed human umbilical vein endothelial cells. Proc Natl Acad Sci USA 2001; 98: 8955-8960.
53. Oyadomari S, Gotoh T, Aoyagi K, Araki E, Shichiri M, Mori M. Coinduction of endothelial nitric oxide synthase and arginine recycling enzymes in aorta of diabetic rats. Nitric Oxide 2001; 5: 252-260.
54. Nagasaki A, Gotoh T, Takeya M et al. Coinduction of nitric oxide synthase, argininosuccinate synthetase, and argininosuccinate Iyase in lipopolysaccharide-treated rats. RNA blot, immunoblot, and immurrohistochemical analyses. J Biol Chem 1996; 271: 2658-2662.
55. Flam BR, Hartmann PJ, Harrell-Booth M, Solomonson LP, Eichler DC. Caveolar localization of arginine regeneration enzymes, argininosuccinate synthase, and lyase, with endothelial nitric oxide synthase. Nitric Oxide 2001; 5: 187-197.
56. Abu-Absi SF, Friend JR, Hansen LK, Hu W-S. Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp Cell Res 2002; 274: 56-67.
57. Saheki T, Komorizono K, Miura T, Ichiki H, Yagi Y, Hashimoto S. Clearance of argininosuccinate synthetase from the circulation in acute liver disease. Clin Biochem 1990; 23: 139-141.